Treatment for primary CNS lymphoma: The next step Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Central Nervous System Neoplasms
  • Lymphoma, Non-Hodgkin

abstract

  • Increasing the dose of MTX and adding procarbazine and vincristine improved disease control and overall survival in patients with newly diagnosed PCNSL. Younger patients in particular fared extremely well with this treatment regimen. In older patients, deferring whole-brain RT did not compromise overall survival but did reduce treatment-related toxicity.

publication date

  • September 18, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10963643

Additional Document Info

start page

  • 3144

end page

  • 50

volume

  • 18

number

  • 17